These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


357 related items for PubMed ID: 25424146

  • 1. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
    Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW.
    Int Wound J; 2015 Dec; 12(6):724-32. PubMed ID: 25424146
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
    Zelen CM, Serena TE, Gould L, Le L, Carter MJ, Keller J, Li WW.
    Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
    [Abstract] [Full Text] [Related]

  • 3. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers.
    Zelen CM, Serena TE, Denoziere G, Fetterolf DE.
    Int Wound J; 2013 Oct; 10(5):502-7. PubMed ID: 23742102
    [Abstract] [Full Text] [Related]

  • 4. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS.
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [Abstract] [Full Text] [Related]

  • 5. Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft.
    Bianchi C, Tettelbach W, Istwan N, Hubbs B, Kot K, Harris S, Fetterolf D.
    Int Wound J; 2019 Jun; 16(3):761-767. PubMed ID: 30864259
    [Abstract] [Full Text] [Related]

  • 6. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM, Caporusso J, Vayser D, Davis RD, Alvarez OM, Sabolinski ML.
    J Wound Care; 2024 Jul 01; 33(Sup7):S4-S14. PubMed ID: 38973638
    [Abstract] [Full Text] [Related]

  • 7. A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers.
    Bianchi C, Cazzell S, Vayser D, Reyzelman AM, Dosluoglu H, Tovmassian G, EpiFix VLU Study Group.
    Int Wound J; 2018 Feb 01; 15(1):114-122. PubMed ID: 29024419
    [Abstract] [Full Text] [Related]

  • 8. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human amnion/chorion membrane allograft in the management of diabetic foot ulcers.
    Zelen CM, Serena TE, Snyder RJ.
    Int Wound J; 2014 Apr 01; 11(2):122-8. PubMed ID: 24618401
    [Abstract] [Full Text] [Related]

  • 9. Apligraf in the treatment of neuropathic diabetic foot ulcers.
    Edmonds M, European and Australian Apligraf Diabetic Foot Ulcer Study Group.
    Int J Low Extrem Wounds; 2009 Mar 01; 8(1):11-8. PubMed ID: 19189997
    [Abstract] [Full Text] [Related]

  • 10. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ, Jacobs AM, Zelen CM.
    Int Wound J; 2018 Dec 01; 15(6):950-957. PubMed ID: 30019528
    [Abstract] [Full Text] [Related]

  • 11. The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
    Kraus I, Sabolinski ML, Skornicki M, Parsons NB.
    Wounds; 2017 May 01; 29(5):125-132. PubMed ID: 28570252
    [Abstract] [Full Text] [Related]

  • 12. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP, Plosker GL.
    BioDrugs; 2002 May 01; 16(6):439-55. PubMed ID: 12463767
    [Abstract] [Full Text] [Related]

  • 13. Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.
    Guest JF, Atkin L, Aitkins C.
    Int Wound J; 2021 Dec 01; 18(6):889-901. PubMed ID: 33827144
    [Abstract] [Full Text] [Related]

  • 14. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ, Shimozaki K, Tallis A, Kerzner M, Reyzelman A, Lintzeris D, Bell D, Rutan RL, Rosenblum B.
    Wounds; 2016 Mar 01; 28(3):70-7. PubMed ID: 26978860
    [Abstract] [Full Text] [Related]

  • 15. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
    Abdo RJ.
    J Wound Care; 2016 Jul 01; 25(Sup7):S4-S9. PubMed ID: 29027851
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Dehydrated Human Amnion Chorion Membrane in the Treatment of Diabetic Foot Ulcers: A Review.
    Au AS, Leung WY, Stavosky JW.
    J Am Podiatr Med Assoc; 2021 Mar 01; 111(2):. PubMed ID: 33872365
    [Abstract] [Full Text] [Related]

  • 17. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J, Dove C.
    Int Wound J; 2019 Feb 01; 16(1):122-130. PubMed ID: 30246926
    [Abstract] [Full Text] [Related]

  • 18. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds. The Apligraf Burn Study Group.
    Waymack P, Duff RG, Sabolinski M.
    Burns; 2000 Nov 01; 26(7):609-19. PubMed ID: 10925183
    [Abstract] [Full Text] [Related]

  • 19. Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers.
    Steinberg JS, Edmonds M, Hurley DP, King WN.
    J Am Podiatr Med Assoc; 2010 Nov 01; 100(1):73-7. PubMed ID: 20093548
    [Abstract] [Full Text] [Related]

  • 20. The Use of Micronized Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers: A Case Series.
    Hawkins B.
    Wounds; 2016 May 01; 28(5):152-7. PubMed ID: 27191173
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.